Dachaigh › Dermatomyositis
Sgrùdaidhean clionaigeach Dermatomyositis a’ fastadh anns na SA
Tha 26 sgrùdaidhean airson Dermatomyositis a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Durham, NC8 sgrùdaidhean
- Washington, DC7 sgrùdaidhean
- New York City, NY5 sgrùdaidhean
- Pittsburgh, PA5 sgrùdaidhean
- Houston, TX5 sgrùdaidhean
- Boston, MA5 sgrùdaidhean
- Philadelphia, PA4 sgrùdaidhean
- Baltimore, MD4 sgrùdaidhean
- Miami, FL4 sgrùdaidhean
- Cleveland, OH3 sgrùdaidhean
- Jacksonville, FL3 sgrùdaidhean
- Kansas City, KS3 sgrùdaidhean
- Aurora, CO3 sgrùdaidhean
- New Haven, CT3 sgrùdaidhean
- Phoenix, AZ3 sgrùdaidhean
Le stàit
- Arizona4 sgrùdaidhean
- California9 sgrùdaidhean
- Colorado4 sgrùdaidhean
- Connecticut3 sgrùdaidhean
- Florida7 sgrùdaidhean
- Illinois3 sgrùdaidhean
- Kansas4 sgrùdaidhean
- Maryland9 sgrùdaidhean
- Massachusetts5 sgrùdaidhean
- New York6 sgrùdaidhean
- North Carolina8 sgrùdaidhean
- Ohio5 sgrùdaidhean
- Pennsylvania7 sgrùdaidhean
- Texas6 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)
A’ fastadhÌre 2
Aoisean 18 gu 60 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07111065Environmental Risk Factors for the Anti-synthetase Syndrome
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 2 gu 100 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT01276470A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06455449Natural History of Inflammatory Muscle Diseases
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 2 gu 120 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT05738824Adult and Juvenile Myositis
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 2 gu 100 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT00017914Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT03816345RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
A’ fastadhÌre 2/3
Aoisean 6 gu 75 · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT06154252A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
A’ fastadhÌre 1
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT06916806A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT05895786A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
A’ fastadhÌre 1
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT07085104FT839 in Autoimmune Diseases
A’ fastadhÌre 1/2
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT07800871A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT06698796Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT07486869Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
A’ fastadhÌre 1/2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 27 Iuch 2026 · NCT07089121Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
A’ fastadhÌre 1
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 22 Iuch 2026 · NCT06371417A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Iuch 2026 · NCT07115745Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Iuch 2026 · NCT07138898Intralesional Injection of STS in Treatment of Calcinosis
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Cèit 2026 · NCT06672822Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM)
A’ fastadhÌre 2/3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 27 Gibl 2026 · NCT07160205Clinical Responsiveness of Dermatomyositis Using Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI)
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Màrt 2026 · NCT02945345Rheumatology Patient Registry and Biorepository
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 18 gu 99 · Gach gnè · Air ùrachadh 13 Gearr 2026 · NCT04402086A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Gearr 2026 · NCT07403188MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
A’ fastadhSgrùdadh amharc
Aoisean 7 agus nas sine · Gach gnè · Air ùrachadh 28 Faoi 2026 · NCT07374107Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis
A’ fastadhÌre 2
Aoisean 18 gu 89 · Gach gnè · Air ùrachadh 8 Dàmh 2025 · NCT06857240Study of KYV-101 Anti-CD19 CAR T Therapy in Adult Dermatomyositis
A’ fastadhÌre 1
Aoisean 25 gu 72 · Gach gnè · Air ùrachadh 21 Cèit 2025 · NCT06298019Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.